Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Hologic, Inc. of $1 billion aggregate principal amount of its 5.250% senior notes due 2022. Hologic intends to use the proceeds of the offering to redeem its outstanding 6.25% senior notes due 2020 and to make a final interest payment thereon.  

Hologic is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. Hologic’s core business units focus on diagnostics, breast health, GYN surgical and skeletal health.  

The Davis Polk capital markets team included partner Michael Kaplan, counsel Derek Dostal and associate Alexander Kerchner. The tax team included partner Michael Farber and associate Ariel David Siman. The environmental team included counsel Loyti Cheng and associate Michael Comstock. Partner Pritesh P. Shah provided intellectual property advice. All members of the Davis Polk team are based in the New York office.  

Copy link to share post